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The Editorial on the Research Topic
With Obesity Becoming the New Normal, What ShouldWe Do?
In just a blink oft Earth’s eye (approximately three decades), obesity has become a global epidemic
and an urgent health crisis due to its impact on health services and the loss of human capital. It
is not just a crisis for health professionals, health economists, and government officials managing
finite resources and considering the economics of premature loss of life and economic productivity:
it is a major societal concern that challenges the way we think about and manage resources. These
resources can be considered in terms of health, human, budgetary, financial, and primary products.
In this timely Frontiers Research Topic, researchers from a breadth of disciplines internationally
contributed reviews, meta-analyses, and novel data on the challenges obesity presents in attempts
to stimulate debate on ways forward.
The impact of modernity on body composition homeostasis is reviewed by Tremblay who
challenges us to reconsider the paradigm that imbalances between food intake and physical activity
are the only determinants of the obesity epidemic, given that complexities within the energy
balance equation prevent a reductionist approach. Factors influencing or regulating the endocrine
responses to energy-in and energy-out are discussed, including the impacts of contemporary
lifestyle: alterations in the sleep-wake cycle, shortened sleep duration, environmental pollutants,
high mental cognitive work, and stress. The challenge of weight loss maintenance in the face of
an endocrine system that has evolved to defend body fat stores and promote weight regain is
examined. The solution? In the face of the obesity pandemic, promotion of the healthiest lifestyle
possible. We should not be limited by focusing solely on energy balance, but holistically intervene
on sleep hygiene, reducing stress responses, and limiting environmental exposure to pollutants
and endocrine disruptor chemicals, all with the aim of down-regulating the central-, adrenal-,
and adipokine-regulating hormonal responses that mitigate an individual’s hard won weight loss.
Whilst government intervention is required to address some of these factors (such as creating
safe environments), clinicians can play an important role in guiding patients to battle against
the regulatory pathways and modernity factors that promote weight regain. With this in mind,
clinicians must realize that the work is not done when weight loss is achieved: we keep our obese
patients for our working life, as they will require ongoing guidance, supervision, and intervention.
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Where governments have shown leadership in developing and
implementing policies to address obesity, the presence of bias
or influence is a significant concern. In an environment where
everyone is an “expert” on diet and obesity [informed from
diverse sources including media, talk-show hosts, reality and
lifestyle programs, advertorials, internet blogs and (occasionally)
real science], do obesity policy makers and service deliverers
bring their own prejudices to the execution of professional
duty? Pengilley and Kelly demonstrate that uninformed opinion
does influence policy implementation. They recommend that
development and design of obesity policy requires a strict,
robust, and transparent governance framework to prevent these
prejudices from derailing the efficacy, reach, and delivery of
obesity policy. Their findings and comments are prophetic,
published just months before The Lancet published evidence
of undue influence by a multinational sweetened beverage
corporation on obesity science and policy in China (1) and,
separately, Milbank Quarterly published evidence of efforts
by a multinational beverage corporation to influence the US
Centers for Disease Control and Prevention (2). A strongly
worded editorial in Lancet Oncology very recently stated that
“Governments must not allow their public health strategies to
be unduly influenced by powerful multinationals who might be
more concerned with protecting their own interests than helping
to solve this ongoing health crisis ” (3).
Where government has implemented population-based
obesity prevention interventions, proof of cost-effectiveness is
vital, given precious health resources. The paper from Döring
et al. evaluated the cost-effectiveness of PRIMROSE, a program
aimed at Swedish pre-school children that addressed healthy
eating and physical activity, with the primary outcome of
BMI at age 4. Cost-effectiveness was not established, due to
the cost of educating nurses to implement the program and
parental income lost to attend. These results raise a number of
questions for intervention implementation (e.g., utilizing trained
but less expensive staff). As obesity impacts on sick leave and
reduced productivity at work, employers are understandably
focused on their employees’ health. Feldman et al. examined
the effectiveness of a workplace wellness program in obese
attendees and found that whilst the program was associated
with only very modest weight loss, the weight loss was clinically
meaningful in attendees who were ready for change. These
findings assist in determining weight loss resource allocation for
greatest impact. Thus, publicly and privately funded initiatives
for obesity reduction are likely to make very little or only a
modest dint in the obesity epidemic. The serious fundamental
question in the modern epidemic of obesity is: does the solution
lie in influencing the choices individuals make in an obesogenic
environment (marketing works commercially, especially for
foods), or is it altering or limiting the choices available to
individuals, using legislation if the food industry insufficiently
responds to the obesity crisis? Can we learn anything from the
efficacy of government legislations that, for example, restricted
the sale of alcohol (Sweden), highly taxed cigarettes (Ireland),
or introduced plain packaging and graphic warnings on tobacco
products (Australia)? (4). Each represented a government
legislative response to harmful products and have reduced
consumption and the adverse health outcomes associated with
each product. Sugar taxes are hotly debated internationally. A
recently published review showed that excise taxation of tobacco,
alcohol, and sweetened beverage works in reducing consumption
(5). Provocative food for thought.
Following on from the theme of childhood obesity prevention
are three papers that report factors associated with childhood
obesity and the surprising lack of cardiometabolic risk reduction
with weight loss intervention. Corica et al. present sobering
data in obese children aged 2–17 years, demonstrating high
rates of obesity and cardiometabolic disease within the family;
extreme youth did not protect against a deteriorated metabolic
profile. Dalla Valle et al. similarly reported an almost universal
presence of at least one cardiometabolic risk factor in obese
children aged 2–17 years; obesity intervention did not improve
these without a very substantive weight loss. When we consider
obesity-accelerated diseases such as diabetes, heart disease, and
cancer and the known consequent reduced life expectancy,
these data indicate the urgent need for effective public health
preventative measures, in addition to family-based interventions
addressing intergenerational factors and treating not only the
aﬄicted children, but also their parents.
Relevant to childhood obesity is consideration of the impact of
obesity on reproductive health and the intrauterine environment,
since excess maternal weight and weight gain in pregnancy
adversely affects birth weight and subsequent childhood obesity
risk. Obesity impacts the risk for polycystic ovary syndrome
and reduces fertility and success of assisted reproduction.
Additionally, maternal obesity impacts the risk of pre-eclampsia
and gestational diabetes, unplanned Cesarean section and fetal
and neonatal outcomes: not limited to premature delivery,
neonatal hypoglycaemia, macrosomia, and childhood-onset of
obesity. The impact of obesity on the efficacy and outcomes
of assisted reproduction, reviewed by Tziomalos and Dinas
examines these issues in polycystic ovary syndrome, including
the evidence for weight reduction prior to assisted reproduction,
recommending deferment of conception until a healthier weight
is achieved.
When the impact of intrauterine over-nutrition and
macrosomia on obesity risk in childhood are considered, a
rationale for public health measures for healthy maternal weight
throughout the reproductive years is justified. Farpour-Lambert
et al. examined the evidence for lifestyle interventions during
pregnancy and postpartum impacting maternal and neonatal
outcomes, reporting that they reduce gestational weight gain,
pregnancy-induced hypertension, the need for Cesarean section
and neonatal respiratory distress syndrome, without any risk of
harm to the mother or neonate. These benefits were observed
across all BMI categories. Dietary interventions were associated
with the greatest reduction of gestational diabetes, pregnancy-
associated hypertension and preterm birth. The synthesis of the
evidence reviewed substantiates that a low glycaemic load and
30–60min of physical activity most days should become health
policy directives for women during pregnancy and postpartum.
In response to the Farour-Lambert paper, Skouteris et al. call
attention to the lack of any international consensus guidelines
on weight management pre-conception. The impact of weight
Frontiers in Endocrinology | www.frontiersin.org 2 April 2019 | Volume 10 | Article 250
Samaras et al. Obesity: Clinical, Research, Economic, Political Strategies
status in the pre-conception phase on fertility, pregnancy and
subsequent maternal and infant outcomes is reviewed. The
importance of efforts to improve the lifestyle and weight status
of mothers-to-be is highlighted, with calls for international
efforts. Thus, healthy lifestyle and weight in the pre-conception
period and during pregnancy are critical factors in assisting
newborns get off to the best start as they enter our brave new
obesogenic world.
Moving away from policy, politics, and lifestyle interventions,
this Research Topic includes papers enlarging our scientific
understanding of energy homeostasis and its links to
other organ systems. A challenge to clinicians treating and
researchers investigating people with obesity is predicting
energy expenditure. In a large population of morbidly obese
participants, Cancello et al. examined existing models for energy
expenditure calculation against indirect calorimetry. They found
most models inaccurate and recommended indirect calorimetry.
The fascinating interface of gut hormone regulation in
response to nutrient intake and how these hormones regulate
appetite and metabolism are reviewed by Hope et al. particularly
in how these hormones respond to fasting, bariatric surgery
and with pharmaceutical analogs. Future therapies are discussed;
particular consideration is given to the co-targeting of multiple
regulatory pathways in order to tackle the many different ways
that human physiology has evolved to defend energy stores in
the face of (potentially life-threatening) energy deficiency. Thus
far, science is yet to detect a hormonal or chemical signal that
effectively says: “stop eating, our adipose stores are full.” We
are challenged to determine how to enhance the effects of the
homeostatic effects of important gut hormones.
The central regulation of food intake is a key factor in
obesity development: what makes some people say “enough”
and other to say “more please” when faced with the same
meal or more food? Over three decades, the number of players
regulating the physiology of appetite and satiety has expanded
rapidly resulting in a greater understanding of the role of
numerous newly discovered gut peptides and the contribution
of circadian and stress hormones. Lasschuijt et al. present
novel data examining the impact of oro-sensory and central
pathways involved in the endocrine response to food ingestion,
specifically, the effects of the duration of chewing food and sweet
taste intensity on satiety and endocrine responses. In a series
of elegant experiments, healthy weight participants consumed
isocaloric foods of differing textures and sweetness but with
similar macronutrient composition followed by measurement
of hormonal responses and subsequent food intake. Modest
increases were found in pancreatic polypeptide following hard-
sweet food ingestion. Interestingly, eating and spitting out the
food was associated with higher acute insulin responses. These
data suggest that hormonal responses are affected by food
texture, not just sweetness or caloric content. The act of chewing
impacts hormonal responses to food, even without ingestion. It is
possible lingual sweet taste receptors may contribute, as we start
to understand the unique endocrinology of the tongue. More
research in this fascinating area is awaited.
Physicians andmetabolic researchers are increasingly aware of
the important role the liver plays, not only as a synthetic factory
for essential proteins and glucose and a passive reservoir for
excess lipid, but as a key regulator of many aspects of metabolism.
It is not only an innocent bystander in the physical onslaught
of obesity but also the victim of the inflammatory effects of
chronic excessive nutrient intake. Obesity is now the commonest
cause of chronic liver disease in countries spared the epidemic of
hepatitis B. The widespread metabolic associates of the spectrum
of non-alcoholic fatty liver disease (NAFLD) are currently being
delineated. Tarantino et al. demonstrate associations between the
presence of obesity-associated NAFLD and carotid artery intima
media thickness, an index of atherosclerosis, apparentlymediated
by the degree of visceral adiposity, age, and haematocrit. These
data add to our understanding in the clinical evaluation of
obese patients.
Depression is closely linked to obesity. Ouakinin et al. review
the evidence for neuroendocrine links between adipose tissue, the
hypothalamus-pituitary-adrenal axis, the sympathetic nervous
system, and circulating and tissue-based inflammation. The
review provides a framework to deepen our understanding of
how energy homeostasis, stress, and neuroendocrine responses
are connected, to the degree that both obesity and depression
share biological mechanisms and pathogenesis.
The search for blood proteins in the early detection of cancers
is a promising area that may improve health outcomes. As
obesity is a major contributor to the risk of many cancers, the
discovery of novel or sentinel markers for early cancer detection
is important. Xu et al. showed that serum zinc-α2-glycoprotein
levels, a newly recognized adipokine, were higher in Chinese
patients with colorectal cancer. Validation of this interesting
finding in larger populations and evaluation of its efficacy as an
early cancer biomarker is awaited.
Epigenetics is an expanding area of interest particularly in
understanding how environmental factors up- or down-regulate
genetic susceptibility to obesity. Zhu et al. review transcription
factors implicated in obesity pathogenesis and mechanisms of
epigenetic modification. This area presents a number of possible
mechanisms by which future interventions may mitigate against
the impact of environmental factors on obesity susceptibility. It
represents an exciting area for future research.
The potential metabolic benefits for traditional
Chinese medicine contribute to the pharmacotherapeutic
armamentarium to battle obesity as reviewed by Huang et al.
examining the evidence for some medicinal components to
improve metabolism. Challenges in translating plant and
animal-based extracts into traditional Western pharmaceuticals
are discussed. Many of our patients purchase supplements with
claims of benefit in an unregulated, frequently not evidence-
based, but highly profitable, supplements environment.
Clinicians who are well-informed on the evidence for
supplements of traditional Chinese medicine are best placed to
advise their patients on where there may or may not benefit.
As editors of this Research Topic, we invited authors to
examine the challenges we face in the broad areas that obesity
impacts. We were rewarded by high quality contributions across
the breadth of medicine, clinical, and fundamental research and
public health. We anticipate the reader is informed by this
collection of articles that embrace the many challenges obesity
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holds for all of us in basic and clinical science, as clinicians, public
health planners, policy makers and consumers. To answer the
question posed by this Research Topic: what should those of us in
the health sciences do? Our mandate is clear, as obesity will erode
all the progress we have made in human health over the last 100
years. First, we require a huge skilled health industry workforce
and physical resources to tackle the health issues that people
with obesity experience today and into the immediate future: we
must train scientists, doctors, and allied health professionals to
effectively treat, alleviate or palliate those suffering from obesity
today and tomorrow. Second, our governments and industries
need to be provided with evidence, so that they understand
they will require deep pockets to support the immense loss of
human and health capital that is occurring now and will do so
for the immediate future, impacting economies internationally.
Third, we must lobby for leadership from forward-looking
and enterprising food industries and corporations to create
products for harm minimization: food of lower energy content,
smaller portion size, foods that promote satiety not hunger, an
ethos of not promoting over-consumption. We must encourage
food industry “disruptors”: enterprising food producers and
manufacturers ready to exploit the opportunities presented in a
market of consumers demanding better foods, when “old school”
food industry doesn’t respond with real change (only cosmetic
or cynical change). Finally, we suggest that our policy makers
and politicians should respond with taxation, levies, and laws
that protect one of the most valued resources our society has:
human health. Many governments have done so with other
toxic substances, such as cigarettes and alcohol, occupational
and environmental hazards. Such legislations are present already
in some countries and cities, with sugar taxation and portion
size limits: these could be extended elsewhere. Imagine a
world however, where these measures were not required.
Imagine a world where food is nourishing and beneficial,
not harmful.
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